Correction: Targeting of IL-10R on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells

Correction: Targeting of IL-10R on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells

Bibliographic Details
Main Authors:	Nianci Chen, Yingxi Xu, Junli Mou, Qing Rao, Haiyan Xing, Zheng Tian, Kejing Tang, Min Wang, Jianxiang Wang
Format:	Article
Language:	English
Published:	Nature Publishing Group 2022-03-01
Series:	Blood Cancer Journal
Online Access:	https://doi.org/10.1038/s41408-022-00627-3

Similar Items

Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells
by: Ying Wang, et al.
Published: (2018-05-01)

Hyperfunction of CD4 CD25 regulatory T cells in de novo acute myeloid leukemia
by: Yuling Wan, et al.
Published: (2020-05-01)

Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)‐T therapy has potential to reduce escape from single‐target CAR‐T with no more hematotoxicity
by: Zhenzhen Wang, et al.
Published: (2023-10-01)

Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia
by: Mingxue Fan, et al.
Published: (2017-08-01)

2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies
by: Yingxi Xu, et al.
Published: (2019-05-01)

Chimeric antigen-receptor (CAR) engineered natural killer cells in a chronic myeloid leukemia (CML) blast crisis model
by: Jusuf Imeri, et al.
Published: (2024-01-01)

Challenges and Advances in Chimeric Antigen Receptor Therapy for Acute Myeloid Leukemia
by: Jennifer Marvin-Peek, et al.
Published: (2022-01-01)

Targets for chimeric antigen receptor T-cell therapy of acute myeloid leukemia
by: Christopher Schorr, et al.
Published: (2022-12-01)

<i>AML1-ETO</i>-Related Fusion Circular RNAs Contribute to the Proliferation of Leukemia Cells
by: Ying Wang, et al.
Published: (2022-12-01)

Chimeric Antigen Receptor T Cell Therapy in Acute Myeloid Leukemia: Trials and Tribulations
by: Swati Garg, et al.
Published: (2023-11-01)

Current Limitations and Perspectives of Chimeric Antigen Receptor-T-Cells in Acute Myeloid Leukemia
by: Marius Maucher, et al.
Published: (2021-12-01)

Anti-CD19 chimeric antigen receptor targeting of CD19 + acute myeloid leukemia
by: Gina Ma, et al.
Published: (2018-01-01)

Chimeric antigen receptor T-cell therapy in the treatment of acute myeloid leukemia: Possible challenges
by: Rahul Jagdishchandra Mittal, et al.
Published: (2021-01-01)

Chimeric antigen receptor (CAR) modified T Cells in acute myeloid leukemia: limitations and expectations
by: Beatriz Guijarro-Albaladejo, et al.
Published: (2024-04-01)

Successful treatment of T315I BCR-ABL mutated lymphoid blast phase chronic myeloid leukemia with chimeric antigen receptor T cell therapy followed by dasatinib
by: Hao Zhang, et al.
Published: (2020-06-01)

Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia
by: Vincent Alcazer, et al.
Published: (2022-07-01)

Chimeric Antigen Receptor T-Cell Therapy in Acute Myeloid Leukemia: State of the Art and Recent Advances
by: Martina Canichella, et al.
Published: (2023-12-01)

Pediatric chronic myeloid leukemia in myeloid blast crisis
by: Biswajit Dey, et al.
Published: (2023-04-01)

Heterogeneous leukemia stem cells in myeloid blast phase chronic myeloid leukemia
by: Kinstrie, R, et al.
Published: (2016)

A novel fusion protein TBLR1-RARα acts as an oncogene to induce murine promyelocytic leukemia: identification and treatment strategies
by: Shouyun Li, et al.
Published: (2021-06-01)

Chimeric Antigen Receptor (CAR)-Modified Immune Effector Cell Therapy for Acute Myeloid Leukemia (AML)
by: Utkarsh H. Acharya, et al.
Published: (2020-12-01)

Chimeric Antigen Receptor T Cells Targeting Cell Surface GRP78 to Eradicate Acute Myeloid Leukemia
by: Wei Yu, et al.
Published: (2022-08-01)

Current Management of Chronic Myeloid Leukemia Myeloid Blast Phase
by: Binoy Yohanan, et al.
Published: (2022-12-01)

Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia
by: Justin C. Boucher, et al.
Published: (2023-12-01)

Blast phase of chronic myeloid leukemia presenting as early T‐cell precursor lymphoblastic leukemia
by: Lianqun Qiu, et al.
Published: (2021-11-01)

Blast crisis in chronic myeloid leukemia: An immunophenotypic analysis
by: Singh Akanksha, et al.
Published: (2022-01-01)

A novel and efficient CD22 CAR-T therapy induced a robust antitumor effect in relapsed/refractory leukemia patients when combined with CD19 CAR-T treatment as a sequential therapy
by: Yu Zhang, et al.
Published: (2022-03-01)

Outcomes with chimeric antigen receptor t-cell therapy in relapsed or refractory acute myeloid leukemia: a systematic review and meta-analysis
by: Moazzam Shahzad, et al.
Published: (2023-04-01)

Molecular Insight into Iron Homeostasis of Acute Myeloid Leukemia Blasts
by: Emmanuel Pourcelot, et al.
Published: (2023-09-01)

Therapy related acute myeloid leukemia with blast cannibalism and cytophagocytosis
by: Habib Moshref Razavi, et al.
Published: (2020-07-01)

CD117 expression on blast cells in acute myeloid leukemia
by: Goryainova N.V., et al.
Published: (2015-09-01)

Chimeric Antigen Receptor T Cells Targeting NKG2D-Ligands Show Robust Efficacy Against Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia
by: Lina Driouk, et al.
Published: (2020-12-01)

Improved Activity against Acute Myeloid Leukemia with Chimeric Antigen Receptor (CAR)-NK-92 Cells Designed to Target CD123
by: Michael A. Morgan, et al.
Published: (2021-07-01)

Mature plasmacytoid dendritic cells associated with acute myeloid leukemia show similar genetic mutations and expression profiles to leukemia cells
by: Xiaoyuan Gong, et al.
Published: (2022-01-01)

Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
by: Yixin Zou, et al.
Published: (2018-11-01)

Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
by: Runxia Gu, et al.
Published: (2020-09-01)

Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells
by: Phatchanat Klaihmon, et al.
Published: (2023-11-01)

B-Lymphoid Blast Phase–Chronic Myeloid Leukemia: Current Therapeutics
by: Binoy Yohannan, et al.
Published: (2022-10-01)

Hemophagocytosis by acute myeloid leukemia blasts associated to poor clinical outcomes
by: Zangbéwendé Guy Ouedraogo, et al.
Published: (2022-05-01)

Megakaryocytic blast crisis in chronic myeloid leukemia: A primary presentation
by: Komal Mahendra Ashar, et al.
Published: (2017-01-01)